<?xml version="1.0" encoding="UTF-8"?>
<p>Ma et al. reported indole based BTA derivatives and studied their anticancer activities. Among all these derivatives, the chlorobenzyl indole semicarbazide benzothiazole 
 <bold>55</bold> (
 <xref ref-type="fig" rid="F0034">Figure 34</xref>) exhibited anticancer activity against four cancer cell lines such as HT-29, H460, A549 and MDA-MB-231. Derivative 
 <bold>55</bold> showed IC
 <sub>50</sub> values of 0.024 µM for HT-29, 0.29 µM for H460, 0.84 µM for A549 and 0.88 µM for MDA-MB-231, respectively
 <xref rid="CIT0056" ref-type="bibr">
  <sup>56</sup>
 </xref>.
</p>
